Methods and compositions for treating cystic fibrosis
US11052132B2 · kind B2 · utility
0Cited by
96References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2015 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | May 8, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a method of treating diseases or disorders associated with CFTR protein dysfunction, including Cystic Fibrosis, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.